| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The FASEB Journal, Vol 10, 882-890, Copyright © 1996 by The Federation of American Societies for Experimental Biology
RESEARCH COMMUNICATIONS |
I Antolin, C Rodriguez, RM Sainz, JC Mayo, H Uria, ML Kotler, MJ Rodriguez- Colunga, D Tolivia and A Menendez-Pelaez
Departamento de Morfologia y Biologia Celular, Universidad de Oviedo,Spain.
It is well known that porphyrins cause a toxic light-mediated effect due to their capability to generate free radicals. Several reports have proved that melatonin is a potent free radical scavenger. The aim of this work has been to study the ability of melatonin to prevent the cell damage caused by porphyrins in the Harderian gland of female Syrian hamsters. Cell injury was evaluated estimating the percentage of damaged cells found in the gland and analyzing the degree of this damage at ultrastructural level. To explain the mechanism by which this hormone could prevent the cell damage caused by porphyrins, its capability to both decrease porphyrin synthesis and increase the mRNA levels for antioxidant enzymes was evaluated. Our results demonstrate that melatonin administration decreases the percentage of damaged cells, porphyrin synthesis, and aminolevulinate synthase (ALA-S) mRNA levels and increases the mRNA levels for manganese superoxide-dismutase and copper-zinc superoxide dismutase. When observed under an electron microscope, the lesions in the clear cells of the treated females were much less severe than in the corresponding cells of the control animals. Melatonin exerts a cytoprotective effect by inhibiting the ALA- S gene expression (and so porphyrin synthesis) and by raising the mRNA levels for several antioxidant enzymes.
This article has been cited by other articles:
|
|
 |
|
  M I Rodriguez, G Escames, L C Lopez, J A Garcia, F Ortiz, A Lopez, and D Acuna-Castroviejo Melatonin administration prevents cardiac and diaphragmatic mitochondrial oxidative damage in senescence-accelerated mice J. Endocrinol., September 1, 2007; 194(3): 637 - 643. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Acuna-Castroviejo A new guest playing with bone and fat Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2007; 292(6): R2206 - R2207. [Full Text] [PDF]
|
|
|
|
 |
|
 M. C. ALBERTINI, F. RADOGNA, A. ACCORSI, F. UGUCCIONI, L. PATERNOSTER, C. CERELLA, M. DE NICOLA, M. D'ALESSIO, A. BERGAMASCHI, A. MAGRINI, et al. Intracellular Pro-oxidant Activity of Melatonin Deprives U937 Cells of Reduced Glutathione without Affecting Glutathione Peroxidase Activity Ann. N.Y. Acad. Sci., December 1, 2006; 1091(1): 10 - 16. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Martin, F. Herrera, P. Carrera-Gonzalez, G. Garcia-Santos, I. Antolin, J. Rodriguez-Blanco, and C. Rodriguez Intracellular Signaling Pathways Involved in the Cell Growth Inhibition of Glioma Cells by Melatonin Cancer Res., January 15, 2006; 66(2): 1081 - 1088. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. N. Anisimov Effects of Exogenous Melatonin--A Review Toxicol Pathol, October 1, 2003; 31(6): 589 - 603. [Abstract] [PDF]
|
|
|
|
 |
|
 N. Delibas, I. Altuntas, Z. Yonden, and N. Ozcelik Ochratoxin a reduces NMDA receptor subunits 2A and 2B concentrations in rat hippocampus: partial protective effect of melatonin Human and Experimental Toxicology, June 1, 2003; 22(6): 335 - 339. [Abstract] [PDF]
|
|
|
|
|
|
R. J. REITER, R. M. SAINZ, S. LOPEZ-BURILLO, J. C. MAYO, L. C. MANCHESTER, and D. X. TAN Melatonin Ameliorates Neurologic Damage and Neurophysiologic Deficits in Experimental Models of Stroke Ann. N.Y. Acad. Sci., May 1, 2003; 993(1): 35 - 47. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. J. Reiter and D.-X. Tan Melatonin: a novel protective agent against oxidative injury of the ischemic/reperfused heart Cardiovasc Res, April 1, 2003; 58(1): 10 - 19. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Vijayalaxmi, C. R. Thomas Jr, R. J. Reiter, and T. S. Herman Melatonin: From Basic Research to Cancer Treatment Clinics J. Clin. Oncol., May 15, 2002; 20(10): 2575 - 2601. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. J. REITER, D. X. TAN, L. C. MANCHESTER, and M. R. EL-SAWI Melatonin Reduces Oxidant Damage and Promotes Mitochondrial Respiration: Implications for Aging Ann. N.Y. Acad. Sci., April 1, 2002; 959(1): 238 - 250. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M Oncu, F Gultekin, E Karaoz, I Altuntas, and N Delibas Nephrotoxicity in rats induced by chlorpryfos-ethyl and ameliorating effects of antioxidantsy Human and Experimental Toxicology, April 1, 2002; 21(4): 223 - 230. [Abstract] [PDF]
|
|
|
|
|
|
R. J. REITER, D. ACUNA-CASTROVIEJO, D.-X. TAN, and S. BURKHARDT Free Radical-Mediated Molecular Damage: Mechanisms for the Protective Actions of Melatonin in the Central Nervous System Ann. N.Y. Acad. Sci., June 1, 2001; 939(1): 200 - 215. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Karbownik and R. J. Reiter Antioxidative Effects of Melatonin in Protection Against Cellular Damage Caused by Ionizing Radiation Experimental Biology and Medicine, October 1, 2000; 225(1): 9 - 22. [Abstract] [Full Text]
|
|
|
|
 |
|
 C. HARMS, M. LAUTENSCHLAGER, A. BERGK, D. FREYER, M. WEIH, U. DIRNAGL, J. R. WEBER, and H. HÖRTNAGL Melatonin is protective in necrotic but not in caspase-dependent, free radical-independent apoptotic neuronal cell death in primary neuronal cultures FASEB J, September 1, 2000; 14(12): 1814 - 1824. [Abstract] [Full Text]
|
|
|
|
|
|
P. RAUHALA and C. C. CHIUEH Effects of Atypical Antioxidative Agents, S-nitrosoglutathione and Manganese, on Brain Lipid Peroxidation Induced by Iron Leaking from Tissue Disruption Ann. N.Y. Acad. Sci., January 1, 2000; 899(1): 238 - 254. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. CRESPO, M. MACÍAS, D. POZO, G. ESCAMES, M. MARTÍN, F. VIVES, J. M. GUERRERO, and D. ACUÑA-CASTROVIEJO Melatonin inhibits expression of the inducible NO synthase II in liver and lung and prevents endotoxemia in lipopolysaccharide-induced multiple organ dysfunction syndrome in rats FASEB J, September 1, 1999; 13(12): 1537 - 1546. [Abstract] [Full Text]
|
|
|
|
|
|
R. M. ASAINZ, J. C. MAYO, R. J. REITER, I. ANTOLÍN, M. M. ESTEBAN, and C. RODRÍGUEZ Melatonin regulates glucocorticoid receptor: an answer to its antiapoptotic action in thymus FASEB J, September 1, 1999; 13(12): 1547 - 1556. [Abstract] [Full Text]
|
|
|
|
|
|
R. J. REITER, J. M. GUERRERO, J. J. GARCIA, and D. ACUNA-CASTROVIEJO Reactive Oxygen Intermediates, Molecular Damage, and Aging: Relation to Melatonin Ann. N.Y. Acad. Sci., November 20, 1998; 854(1): 410 - 424. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Gilad, H. R. Wong, B. Zingarelli, L. Virág, M. O'connor, A. L. Salzman, and C. Szabó Melatonin inhibits expression of the inducible isoform of nitric oxide synthase in murine macrophages: role of inhibition of NF{kappa}B activation FASEB J, June 1, 1998; 12(9): 685 - 693. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
